VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
PACS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
PACSPACS Group, Inc.
$49.60$7.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
PACS logo

PACS Group, Inc.

PACS
NYSE · Healthcare Providers
$49.60
At close - Nov 6, 4:00 PM EST - USD
Market Cap$7.85B
P/E29.3x
52W High$51.68
Volume874.67K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q2

Acquisition-Led Growth Faces Thin Margin Pressures

PACS Group's revenue growth is driven by acquisitions, with total revenue reaching $1.4B in 2026Q2, up 19.8% year-over-year, but operating margins remain thin at 5.85%, leaving little cushion against labor cost inflation.

GrowthAccelerating
ProfitabilityStable
ValuationReview
TechnicalsStrong
Explore valuation models
MARKET ACTION

PACS price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

6/12 Beats

EPS beat 6 of last 12 quarters

02

Valuation risk

+31% Peers

P/E is 31% above peer median

03

Market leadership

RS 91 · Leader

High momentum (Outperforming 91% of market)

04

Strong Uptrend

Strong Trend

Price > 20DMA > 50DMA > 200DMA

Next CatalystEstimated earnings · Feb 3

Market performance

Price History →

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
PACS+25.54%
S&P 500 (^GSPC)+7.63%
1-Year Return
PACS+297.44%
S&P 500 (^GSPC)+9.69%
3-Year Return
PACS+115.65%
S&P 500 (^GSPC)+66.57%
5-Year Return
PACS+115.65%
S&P 500 (^GSPC)+54.80%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y Low
29.3x
Forward P/EExpansion
20.5x
EV/EBITDA0th %ile
22.4x
FCF YieldCash Flow
5.7%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
29.3x
34.5x
0th· Low
EV/EBITDA
22.4x
32.3x
0th· Low
Price/FCF
17.5x
111.1x
0th· Low
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$0.13-99.7%
Base (Fair)$17.96-63.8%
Bull$32.75-34.0%
$0.13 Bear$17.96 Base$32.75 Bull
Current Market Price: $49.60
Trades at a 176.2% premium to Base DCF ($17.96)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$5.26B+30.0% YoY
Net income FY25
$192M+243.5% YoY
Free cash flow FY25
$299M+1604.4% YoY
Operating margin FY25
5.9%+2.8 pts YoY
ROIC (FY25)5.4%
Avg ROIC 5Y5.7%
ROE (TTM)25.7%
Piotroski Score8 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate6/12 (55%)
Revenue Beat Rate9/12 (82%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Nov 3, 2026
$0.63+8.8%
vs $0.58
$1.5B+2.7%
vs $1.5B
Q3 2026
Aug 4, 2026
$0.63+17.3%
vs $0.54
$1.4B+1.0%
vs $1.4B
Q2 2026
May 11, 2026
$0.50+19.0%
vs $0.42
$1.4B+4.1%
vs $1.4B
Q1 2026
Feb 26, 2026
$0.43-10.4%
vs $0.48
$1.4B-1.7%
vs $1.4B
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Business Wire·Oct 27, 2026
PACS Group Schedules Third Quarter 2026 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that it intends to report its financial results for the third quarter ended September 30, 2026, on Tuesday, November 3, 2026, after the stock market closes. Management will host a call on Wednesday, November 4, 2026, at 11:30 a.m. ET to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the.

Defense World·Oct 27, 2026
PACS Group (NYSE:PACS) CEO Jason Hulse Murray Sells 68,917 Shares of Stock

PACS Group, Inc. (NYSE: PACS - Get Free Report) CEO Jason Murray sold 68,917 shares of the company's stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $48.60, for a total value of $3,349,366.20. Following the transaction, the chief executive officer directly owned 54,188,200 shares in

Defense World·Oct 27, 2026
PACS Group (NYSE:PACS) CEO Jason Hulse Murray Sells 13,696 Shares of Stock

PACS Group, Inc. (NYSE: PACS - Get Free Report) CEO Jason Murray sold 13,696 shares of the business's stock in a transaction on Thursday, October 22nd. The shares were sold at an average price of $47.55, for a total transaction of $651,244.80. Following the sale, the chief executive officer directly owned 54,257,117 shares in the company,

Defense World·Oct 19, 2026
Insider Selling: PACS Group (NYSE:PACS) CEO Sells $10,440.00 in Stock

PACS Group, Inc. (NYSE: PACS - Get Free Report) CEO Jason Murray sold 232 shares of the business's stock in a transaction dated Wednesday, October 14th. The shares were sold at an average price of $45.00, for a total transaction of $10,440.00. Following the completion of the transaction, the chief executive officer directly owned 54,435,017 shares

Filtered for PACS Group, Inc.More Headlines
04

Compare before deciding

Benchmark PACS against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for PACS Group, Inc. (PACS)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
PACS logoPACSPACS Group, Inc.Current
$49.60$7.85B29.2930.04%4.89%25.65%—
ENSG logoENSGThe Ensign Group, Inc.
$181.08$10.55B26.9118.72%7.03%16.61%0.14%
NHC logoNHCNational HealthCare Corporation
$208.85$3.26B29.0816.94%7.24%10.35%1.18%
ADUS logoADUSAddus HomeCare Corporation
$124.31$2.32B20.7923.21%7.39%9.81%—
SGRY logoSGRYSurgery Partners, Inc.
$23.20$3.03B-33.736.24%-2.63%-2.59%—
CHE logoCHEChemed Corporation
$528.05$7.01B24.564.06%10.61%32.1%0.42%

Compare PACS vs Peers

PACS Group, Inc. (PACS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ENSG

Most directly comparable listed peer for PACS.

Scale Benchmark

vs UNH

Larger-name benchmark to compare PACS against a more recognizable public peer.

Peer Set

Compare Top 5

vs ENSG, NHC, ADUS, SGRY

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

PACS SEC Filings & Documents

PACS Group, Inc. (PACS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Aug 4, 2026·SEC

Material company update

Jun 15, 2026·SEC

Material company update

May 11, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 27, 2026·SEC

FY 2025

Nov 19, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

Aug 4, 2026·SEC

FY 2026

May 11, 2026·SEC

FY 2025

Nov 19, 2025·SEC

Get notified when PACS posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

PACS Frequently Asked Questions

PACS Group, Inc. (PACS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
How fast is PACS Group, Inc. growing?

PACS Group, Inc. (PACS) grew revenue by 11.1% over the trailing twelve months, compared with the twelve months before.

Is PACS profitable?

Yes. PACS Group, Inc. (PACS) earned $277.6M in net income over the trailing twelve months (a 4.9% net margin).

Dividend & Returns
What is PACS's return on equity?

PACS Group, Inc. (PACS) had a return on equity (ROE) of 25.7% over the trailing twelve months. That is well above the market's typical 10-15%.

Industry Metrics
What is PACS Group, Inc.'s net interest margin?

PACS Group, Inc. (PACS) has a net interest margin (NIM) of -0.5%. NIM has been under pressure due to interest rate environment.

What is PACS Group, Inc.'s efficiency ratio?

PACS Group, Inc. (PACS) has an efficiency ratio of 16.2%. This is excellent, indicating strong cost control.

What if you invested $1,000 in PACS back in 2022?

Total return calculator · dividends reinvested · 4+ years of data

See returns →